Revvity Inc. (RVTY)
NYSE: RVTY
· Real-Time Price · USD
91.83
0.49 (0.54%)
At close: May 29, 2025, 3:59 PM
91.91
0.09%
After-hours: May 29, 2025, 06:00 PM EDT
Revvity Revenue Breakdown
| Period Ending | Dec 29, 2024 |
|---|---|
| Diagnostics Revenue | 1.5B |
| Diagnostics Revenue Growth | n/a |
| Life Sciences Revenue | 1.25B |
| Life Sciences Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 29, 2024 |
|---|---|
| China Revenue | 450.01M |
| China Revenue Growth | n/a |
| Other International Revenue | 2.75B |
| Other International Revenue Growth | n/a |
| United Kingdom Revenue | 112.88M |
| United Kingdom Revenue Growth | n/a |
| United States Revenue | 1.1B |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 249.72M | 245.04M | 237.52M | 251.65M | 169.33M | 251.75M | 250.25M | 269.31M | 231.06M | 198M | 233.17M | 245.76M | 334.39M | 355.25M | 339.05M | 281.82M | 251.41M | 263.05M | 225.25M | 221.03M | 208.57M | 210.74M | 204.17M | 201.55M | 198.86M | 210.54M | 196.77M | 204.88M | 199.72M | 172.27M | 150.86M | 147.94M | 145.09M | 162.79M | 145.79M | 153.99M | 147.54M | 158.5M | 147.73M | 146.74M | 145.87M |
| Selling, General, and Administrative Revenue Growth | +1.91% | +3.17% | -5.61% | +48.61% | -32.74% | +0.60% | -7.08% | +16.55% | +16.70% | -15.08% | -5.12% | -26.51% | -5.87% | +4.78% | +20.31% | +12.10% | -4.43% | +16.78% | +1.91% | +5.97% | -1.03% | +3.22% | +1.30% | +1.36% | -5.55% | +7.00% | -3.96% | +2.58% | +15.94% | +14.19% | +1.97% | +1.96% | -10.87% | +11.66% | -5.33% | +4.37% | -6.91% | +7.30% | +0.67% | +0.60% | n/a |
| Research and Development Revenue | 53.6M | 49.21M | 49.14M | 48.13M | 50.36M | 49.6M | 53.04M | 57.25M | 56.69M | 54.54M | 53.52M | 73.35M | 76.61M | 80.32M | 68.61M | 65.82M | 60.22M | 56.82M | 50.13M | 49.52M | 48.91M | 47.64M | 45.38M | 48.34M | 47.98M | 51.97M | 48.85M | 47.2M | 45.98M | 37.67M | 34.89M | 33.56M | 33.29M | 32.93M | 33.17M | 35.01M | 33.78M | 30.03M | 31.09M | 32.68M | 32.12M |
| Research and Development Revenue Growth | +8.92% | +0.13% | +2.10% | -4.42% | +1.54% | -6.49% | -7.36% | +0.99% | +3.95% | +1.90% | -27.04% | -4.25% | -4.62% | +17.07% | +4.23% | +9.31% | +5.97% | +13.35% | +1.23% | +1.24% | +2.68% | +4.98% | -6.14% | +0.76% | -7.68% | +6.39% | +3.50% | +2.64% | +22.08% | +7.97% | +3.95% | +0.82% | +1.10% | -0.75% | -5.23% | +3.62% | +12.50% | -3.42% | -4.86% | +1.75% | n/a |